{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:29:27Z","timestamp":1778509767815,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","derm.theclinics.com","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.det.2017.11.002","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T08:44:43Z","timestamp":1513413883000},"page":"87-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Genetic Predisposition to Rosacea"],"prefix":"10.1016","volume":"36","author":[{"given":"Olabola","family":"Awosika","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Oussedik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.det.2017.11.002_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3810\/pgm.2009.09.2066","article-title":"Updates on the pathophysiology and management of acne rosacea","volume":"121","author":"Elsaie","year":"2009","journal-title":"Postgrad Med"},{"issue":"5","key":"10.1016\/j.det.2017.11.002_bib2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea part I. Introduction, categorization, histology, pathogenesis, and risk factors","volume":"72","author":"Two","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2017.11.002_bib3","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jaad.2013.04.045","article-title":"New insights into rosacea pathophysiology: a review of recent findings","volume":"69","author":"Steinhoff","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2017.11.002_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/exd.13143","article-title":"Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics","volume":"26","author":"Holmes","year":"2017","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.det.2017.11.002_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-2220","article-title":"Rosacea: the blessing of the Celts \u2013 An approach to pathogenesis through translational research","volume":"96","author":"Melnik","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2017.11.002_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/B978-0-12-386960-9.00013-7","article-title":"Vitamin D, vitamin D receptor, and cathelicidin in the treatment of tuberculosis","volume":"86","author":"Selvaraj","year":"2011","journal-title":"Vitam Horm"},{"issue":"3\u20134","key":"10.1016\/j.det.2017.11.002_bib7","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.ddmec.2013.01.001","article-title":"Innate immunity and the role of the antimicrobial peptide cathelicidin in inflammatory skin disease","volume":"10","author":"Roby","year":"2013","journal-title":"Drug Discov Today Dis Mech"},{"key":"10.1016\/j.det.2017.11.002_bib8","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/S0151-9638(11)70087-4","article-title":"Epidemiology of rosacea: updated data","volume":"138","author":"Chosidow","year":"2011","journal-title":"Ann Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2017.11.002_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-3083.2009.03472.x","article-title":"Risk factors associated with rosacea","volume":"24","author":"Abram","year":"2010","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2017.11.002_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"issue":"8","key":"10.1016\/j.det.2017.11.002_bib11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamadermatol.2014.4728","article-title":"Clinical, histologic, and molecular analysis of differences between erythematotelangiectatic rosacea and telangiectatic photoaging","volume":"151","author":"Helfrich","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2017.11.002_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2015.53","article-title":"Assessment of the genetic basis of rosacea by genome-wide association study","volume":"135","author":"Chang","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"issue":"9","key":"10.1016\/j.det.2017.11.002_bib13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genome-wide study","volume":"357","author":"Hafler","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.det.2017.11.002_bib14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.764","article-title":"Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47","volume":"43","author":"Anderson","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.det.2017.11.002_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2016.12.025","article-title":"Sebaceous gland-rich skin is characterized by TSLP expression and distinct immune surveillance which is disturbed in rosacea","volume":"137","author":"Dajnoki","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2017.11.002_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jid.2016.12.013","article-title":"TRPV4 moves toward center-fold in rosacea pathogenesis","volume":"137","author":"Chen","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2017.11.002_bib17","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jid.2016.10.046","article-title":"TRPV4 mediates mast cell activation in cathelicidin-induced rosacea inflammation","volume":"137","author":"Mascarenhas","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2017.11.002_bib18","doi-asserted-by":"crossref","first-page":"E3225","DOI":"10.1073\/pnas.1312933110","article-title":"UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin-1 signaling","volume":"110","author":"Moore","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.det.2017.11.002_bib19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jamadermatol.2015.2230","article-title":"Genetic vs environmental factors that correlate with rosacea","volume":"151","author":"Aldrich","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2017.11.002_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.14413","article-title":"Rosacea and demodicidosis associated with gain-of-function mutation in STAT1","author":"Second","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2017.11.002_bib21","article-title":"Clustering of autoimmune diseases in patients with rosacea","author":"Egeberg","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2017.11.002_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1519","article-title":"Sarcoidosis is associated with a truncating splice site mutation in BTNL2","volume":"37","author":"Valentonyte","year":"2005","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.det.2017.11.002_bib23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/120347541201600615","article-title":"Isotretinoin for the treatment of granulomatous rosacea: case report and review of the literature","volume":"16","author":"Rallis","year":"2012","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"12","key":"10.1016\/j.det.2017.11.002_bib24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1600-0625.2008.00753.x","article-title":"Granulomatous rosacea and Crohn\u2019s disease in a patient homozygous for the Crohn-associated NOD2\/CARD15 polymorphism R702W","volume":"17","author":"Van Steensel","year":"2008","journal-title":"Exp Dermatol"},{"issue":"8","key":"10.1016\/j.det.2017.11.002_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ni1092","article-title":"NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses","volume":"5","author":"Watanabe","year":"2004","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.det.2017.11.002_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ibd.20066","article-title":"NOD2\/CARD15 disease associations other than Crohn's disease","volume":"13","author":"Henckaerts","year":"2007","journal-title":"Inflamm Bowel Dis"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863517301602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863517301602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T02:50:40Z","timestamp":1535165440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863517301602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0733863517301602"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2017.11.002","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic Predisposition to Rosacea","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}